Cutter & CO Brokerage, Inc. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cutter & CO Brokerage, Inc. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$210,000
-28.6%
4,944
-25.6%
0.06%
-17.1%
Q3 2021$294,000
-30.5%
6,644
-10.7%
0.07%
-27.8%
Q2 2021$423,000
-26.4%
7,443
-3.2%
0.10%
-30.7%
Q1 2021$575,000
-34.3%
7,688
-24.0%
0.14%
-39.1%
Q4 2020$875,000
+32.0%
10,117
-6.7%
0.23%
+17.3%
Q3 2020$663,000
+55.6%
10,840
+5.8%
0.20%
+41.0%
Q2 2020$426,000
+86.0%
10,247
+28.8%
0.14%
+61.6%
Q1 2020$229,000
-56.5%
7,957
+9.2%
0.09%
-53.5%
Q4 2019$526,000
-40.9%
7,289
+14.9%
0.18%
-35.3%
Q3 2019$890,000
-23.4%
6,3440.0%0.29%
-22.1%
Q2 2019$1,162,000
+17.6%
6,344
+2.1%
0.37%
+30.6%
Q1 2019$988,000
+79.0%
6,214
+7.9%
0.28%
+33.8%
Q4 2018$552,000
-18.7%
5,759
+19.7%
0.21%
-9.5%
Q3 2018$679,000
-18.3%
4,810
-9.4%
0.23%
-27.5%
Q2 2018$831,000
-2.8%
5,3100.0%0.32%
-5.3%
Q1 2018$855,0000.0%5,310
+2.3%
0.34%
-3.7%
Q4 2017$855,000
+162.3%
5,190
-0.7%
0.35%
+172.1%
Q3 2017$326,000
-22.7%
5,226
-1.3%
0.13%
-22.3%
Q2 2017$422,000
+45.0%
5,296
+29.2%
0.17%
+38.3%
Q1 2017$291,0004,1000.12%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders